← Back
Data updated: Mar 10, 2026
CENCI
Pharmaceuticals
CENCI is a generic drug manufacturer with 12 FDA-approved products.
1982
Since
12
Drugs
-
Trials
10
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
DIPHENHYDRAMINE HYDROCHLORIDE 2025-08-22
DIPHENHYDRAMINE HYDROCHLORIDE 2025-06-24
THEOPHYLLINE 2025-06-13
Labeling
THEOPHYLLINE 2025-06-13
Labeling
THEOPHYLLINE 2025-03-26
THEOPHYLLINE 2025-01-13
THEOPHYLLINE 2024-09-05
THEOPHYLLINE 2024-05-21
DIPHENHYDRAMINE HYDROCHLORIDE 2024-03-20
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (12)
Company Info
- First Approval
- 1982-04-15
- Latest
- 1996-10-23
- Applications
- 12